Y-Intercept (HK)’s Oramed Pharmaceuticals ORMP Stock Holding History

Y-Intercept (HK)’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-12,817	Closed	-$61.6K	–	1965
2026 Q2	$61.6K	Buy	+12,817	New	+$51K	﹤0.01%	1620

Other funds holding ORMP

Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Y-Intercept (HK)'s ORMP Position: Q3 2026 in Review

Y-Intercept (HK) sold out of Oramed Pharmaceuticals (ORMP) in Q3 2026, closing a stake of 12,817 shares — an estimated $61.6K sold.

Y-Intercept (HK) first reported a position in ORMP in Q2 2026 and held it in 1 quarter. The position peaked at $61.6K in Q2 2026. 5 funds tracked by Wall St. Rank hold ORMP as of Q3 2026.

Y-Intercept (HK) reported no remaining Oramed Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
Y-Intercept (HK) sold 12,817 Oramed Pharmaceuticals shares in Q3 2026, an estimated $61.6K.
Y-Intercept (HK) first reported a position in Oramed Pharmaceuticals in Q2 2026 and held it in 1 quarter.
Y-Intercept (HK)'s Oramed Pharmaceuticals position peaked at $61.6K in Q2 2026.
5 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q3 2026.

Based on Y-Intercept (HK)'s 13F filing for Q3 2026, filed 16 Oct 2026.